Neoplasia/BPH

	Cuproptosis-related gene DLD expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. Discov Oncol Qian C, He H, You G. PMID: 41428162 [PubMed - as supplied by publisher]
	Smooth Muscle Disruptive Feature Defines Molecular Subtyping, Risk Stratification, and Metastatic Potential in Prostate Cancer. Ann Surg Oncol Luo Y, Jiang Z, Liu Z, Deng X, Wang J, Su S. PMID: 41428021 [PubMed - as supplied by publisher]
	Design and Synthesis of Novel Chalcone Derivatives Targeting Bladder and Liver Cancer: Cytotoxicity Evaluation and Preliminary Mechanistic Studies. ACS Omega Hermenegildo AM, Nakao IA, Vaz LBA, Coutinho GG, Toledo JLM, Almeida TC, Roquete Amparo T, Anunciação KF, da Silva GN, Brandão GC, Braga SFP, de Souza TB. PMID: 41427178 [PubMed]
	Sarcomatoid and Unclassified Renal Neoplasms: Histology, Immunology, and Genomics. Cureus Qasim H, Hayajneh A, Abuuqteish H, Khattab K, Leoni MLG, Varrassi G. PMID: 41426798 [PubMed]
	Neoadjuvant Therapy to Enable Partial Nephrectomy in Patients With High-Complexity or Locally Advanced Non-metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Cureus Abusal F, Alawadi A, Alsharief M, Zeid A, Obeidat S, Wreikat M, Serag H. PMID: 41426783 [PubMed]
	Development and validation of a nomogram for predicting clinically significant prostate cancer using serologic indices, multiparametric magnetic resonance imaging, and sound touch elastography parameters: a retrospective study. Front Oncol Shu K, Chen Q, Chen J, Xu Q, Jin Y. PMID: 41426319 [PubMed]
	Long non-coding RNAs define favourable biology in high-risk non-muscle-invasive bladder cancer. BJUI Compass Weng R, Phung TAT, Bell R, Dyrskjøt L, Gibb EA. PMID: 41425537 [PubMed]
	Urinary biomarkers in multicentric studies: Shaping the future of bladder cancer diagnosis and follow-up. BJUI Compass Martel A, Raue L, Avogbe PH, Raisch J, Jeldres C, Ecke T, Vian E, Hosen MI, Rabien A, Le Calvez-Kelm F, Boisvert FM. PMID: 41425536 [PubMed]
	Evolving frontiers in bladder cancer immunotherapy: integrating BCG, immune checkpoints, viral vectors, nanotechnology, and CAR-based therapies. Front Cell Dev Biol Di Spirito A, Zuccolotto G, Tosi A, Balkhi S, Rosato A, Baci D, Mortara L. PMID: 41425090 [PubMed]
	Drinking water nitrate, disinfection byproducts, and prostate cancer incidence in the Agricultural Health Study. J Natl Cancer Inst Spaur M, Koutros S, Hurwitz LM, Manley CK, Fisher JA, Ammons S, Madrigal JM, Chen D, Parks CG, Albert PS, Sandler DP, Hofmann JN, Beane Freeman LE, Jones RR, Ward MH. PMID: 41423865 [PubMed - as supplied by publisher]
	High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD). Br J Cancer Nair-Shalliker V, Smith DP, Gebski V, Patel MI, Frydenberg M, Yaxley J, Gardiner R', Espinoza D, Kimlin MG, Dhillon V, Leifert W, Gillatt D, Woo H, Rasiah K, Awad N, Symons J, Wells JK, Pickett HA, Fenech M, Anderson PH, Armstrong BK, Gurney H. PMID: 41423505 [PubMed - as supplied by publisher]
	Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based Studies. Cancer Med Stock SR, Parrish JA, Burns MT, Janes JL, Waller J, De Hoedt AM, Ghate S, Kim J, Shui IM, Freedland SJ. PMID: 41423433 [PubMed - indexed for MEDLINE]
	Artificial intelligence-driven prostate cancer diagnosis: Enhancing accuracy and personalizing patient care. Urol Oncol Zhang X, Xiao N, Liang H, Li P, Zhang Y, Zhang S, Zhou B, Yao S, Yang Z, Chen J. PMID: 41423376 [PubMed - as supplied by publisher]
	Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancer. RMD Open Dauchez A, Dariane C, Fechtenbaum J, Bodard S, Guinebert S, Timsit MO, Roux C, Hyafil F, Briot K, Fogel O. PMID: 41423294 [PubMed - indexed for MEDLINE]
	Metastatic clear cell seminal vesicle carcinoma masquerading as high-grade prostate cancer. BMJ Case Rep M Khamis M, Walters ML, Rodgers HA. PMID: 41423288 [PubMed - indexed for MEDLINE]
	Association of Proteinuria as an Observed Side Effect with a Worsening Rate of Renal Function Decline in Patients with Colorectal Cancer Treated with Bevacizumab. Biol Pharm Bull Yamaguchi K, Fujimoto K, Sakurai M, Horie T, Takahashi Y, Ishigaki Y, Masauji T. PMID: 41423225 [PubMed - indexed for MEDLINE]
	Editorial comment on "Can novel biomarkers augment traditional surveillance paradigms in early-stage testicular germ cell tumors? A case study in pre-clinical relapse detection using a combination micro-RNA-371a-3p and 372-3p assay" (# URL-D-25-02183R1). Urology Dieckmann DK. PMID: 41423088 [PubMed - as supplied by publisher]
	A Daily Clinical Practice Decision-Making Overview for the Present metastatic Renal Cell Carcinoma (mRCC) management landscape. Crit Rev Oncol Hematol Bracarda S, Calabrò F, De Giorgi U, Procopio G, Sabbatini R, Porta C. PMID: 41423067 [PubMed - as supplied by publisher]
	Bacillus Calmette-GuÃ©rin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design. Eur Urol Focus Jazayeri SB, DiNatale RG, Guske C, Harrs C, Linscott J, Xu H, Davaro F, Wen L, Spiess PE, Sexton WJ, Gilbert SM, Zemp L, Poch MA, Li R. PMID: 41421932 [PubMed - as supplied by publisher]
	Re: Nikita Sushentsev, Anne Y. Warren, Richard Colling, et al. Active Monitoring, Surgery, and Radiotherapy for Cribriform-positive and Cribriform-negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.4125. Eur Urol Focus Bernardino R, Le Guevélou J, Autorino R, Gandaglia G, Marra G, Young Academic Urologists Prostate Group. PMID: 41421931 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184146

Page 1 of 9208



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy